Purposefully built for the pharmaceutical industry, the DeepIntent Healthcare Advertising Platform is proven to drive higher audience quality and script performance
NEW YORK, October 10, 2023 — Healthcare advertising technology leader DeepIntent announced that the DeepIntent Healthcare Advertising Platform won “Best Demand-Side Technology” in the 2023 AdExchanger Awards, which celebrates excellence in digital marketing and advertising. DeepIntent was a finalist against leading advertising and marketing technology companies such as Samsung DSP, Scibids, The Trade Desk, and Yahoo Advertising.
Healthcare marketers have traditionally been saddled with multiple platforms to plan, activate, and measure their advertising campaigns. The DeepIntent Healthcare Advertising Platform was built to bridge these siloes for them. By enabling healthcare marketers to run entire programmatic campaigns within a single platform, the DeepIntent Healthcare Advertising Platform makes it far more efficient to reach healthcare providers and patients in a privacy-safe way, and coordinate messaging between the two.
AdExchanger’s Best Demand-Side Technology category awards the ad tech platform that consistently meets the highest standards and shows leadership and innovation in areas like identity, targeting, measurement, partnerships, client services, and marketplace quality. With patented technology and the industry’s most comprehensive health data, the DeepIntent Healthcare Advertising Platform is proven to drive higher audience quality and script performance, ultimately driving better patient outcomes.
“I’m incredibly proud of the DeepIntent team for winning the AdExchanger Award for Best Demand-Side Technology. Seeing a vertical-specific DSP win this award speaks volumes about the progress we’ve made as an industry. As DeepIntent grows and continues to innovate, we remain committed to our core mission of harnessing technology to close the information gap between available treatments, patients, and their providers,” said Chris Paquette, Founder and CEO of DeepIntent.
The AdExchanger Award marks the seventh such win for the DeepIntent Healthcare Advertising Platform. Earlier this year, the platform won a Digiday Media Award for Best Ad Tech Platform, and in 2020, won a Digiday Technology Award in the Best Buy-Side Programmatic Platform category. In addition, DeepIntent won PM360 Innovation Awards four consecutive years for its HCP Planner, Patient Modeled Audiences, DeepIntent Outcomes™, and Audience Marketplace solutions.
With a core belief that advertising technology can measurably improve the lives of patients, DeepIntent is leading the healthcare advertising industry into the future. Built purposefully for the healthcare industry, the DeepIntent Healthcare Advertising Platform is proven to drive higher audience quality and script performance with patented technology and the industry’s most comprehensive health data. DeepIntent is trusted by 600+ pharmaceutical brands and all the leading healthcare agencies to reach the most relevant healthcare provider and patient audiences across all channels and devices. For more information, visit DeepIntent.com or find us on LinkedIn.